Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Phase 3 Unknown
731 enrolled 11 charts
Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer
Phase 3 Unknown
200 enrolled
VOLCANO
Phase 3 Unknown
200 enrolled
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.
Phase 3 Unknown
45 enrolled
LUNG-NEPA
Phase 3 Unknown
261 enrolled
ADJUVANT
Phase 3 Unknown
222 enrolled
Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer
Phase 3 Unknown
200 enrolled
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Phase 3 Unknown
417 enrolled
RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma.
Phase 3 Unknown
78 enrolled
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Phase 3 Unknown
700 enrolled
Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 3 Unknown
400 enrolled
The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.
Phase 3 Unknown
200 enrolled
Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma
Phase 3 Unknown
1,012 enrolled
AMORCE-CBP
Phase 3 Unknown
1,000 enrolled
Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 3 Unknown
630 enrolled
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Phase 3 Unknown
ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Phase 3 Unknown
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 3 Unknown
1,800 enrolled
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 3 Unknown
Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Phase 3 Unknown
200 enrolled
Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Phase 3 Unknown
300 enrolled
LCAN
Phase 3 Unknown
272 enrolled
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
Phase 3 Unknown
750 enrolled
Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma
Phase 3 Unknown
60 enrolled
Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer
Phase 3 Unknown
250 enrolled
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
Phase 3 Unknown
430 enrolled
Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 3 Unknown
1,350 enrolled
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 3 Unknown
Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer
Phase 3 Unknown
242 enrolled
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
Phase 3 Unknown
2,200 enrolled
Concomitant Tracheostomy and Lung Resection
Phase 3 Unknown
60 enrolled
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 3 Unknown
80 enrolled
Trial of a Breathlessness Intervention Service for Intractable Breathlessness
Phase 3 Unknown
120 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
Phase 3 Unknown
280 enrolled
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
Phase 3 Unknown
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
Phase 3 Unknown
600 enrolled